Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MC4R | P32245 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7327576 | 1.00 | KMT2A (0.41) | KMT2AEPHX1THRBCYP2D6MC4R | |
| SCHEMBL9066760 | 0.86 | PTGS2 (0.44) | EPHX1 | |
| SCHEMBL10813004 | 0.77 | CHRNA7 (0.41) | — | |
| SCHEMBL6632699 | 0.75 | CYP3A4 (0.43) | KMT2ACYP2D6LMNA | |
| SCHEMBL28835630 | 0.75 | TDP1 (0.42) | KMT2ATSHR | |
| SCHEMBL16798345 | 0.75 | CA1 (0.52) | THRBCYP2D6TSHRLMNA | |
| SCHEMBL4196376 | 0.75 | AOC3 (0.44) | CYP2D6TSHRHRH1LMNA | |
| SCHEMBL28467958 | 0.75 | MIF (0.39) | CYP2D6DPP4F2TSHRMIF | |
| SCHEMBL16798444 | 0.75 | SLC6A4 (0.48) | KMT2ATSHRLMNA | |
| SCHEMBL6629617 | 0.73 | CFTR (0.48) | TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 517 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2023177250-A1 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 숙명여자대학교산학협력단 | 2023-09-21 | — | — | WO | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-111386331-A | Ester compound, lubricating oil composition containing same, and method for producing same | 埃克森美孚化学专利公司 | 2020-07-07 | — | — | CN | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| WO-2019067061-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-10071984-B2 | Histone demethylase inhibitors | CELGENE QUANTICEL RESEARCH, INC. (US) | 2018-09-11 | — | — | US | claimed |
| US-9676770-B2 | Histone demethylase inhibitors | CELGENE QUANTICEL RESEARCH, INC. (US) | 2017-06-13 | — | — | US | claimed |
| CN-101851238-B | Substituted 8-heteroaryl xanthines | ADENOSINE THERAPEUTICS LLC | 2012-07-18 | — | — | CN | claimed |
| WO-2003099818-A1 | SUBSTITUTED QUINAZOLINONE COMPOUNDS | CHIRON CORPORATION (US) | 2003-12-04 | — | — | WO | claimed |
| EP-0758320-A1 | TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS | Allelix Biopharmaceuticals Inc. (CA) | 1997-02-19 | — | — | EP | claimed |
| WO-1995030655-A1 | TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1995-11-16 | — | — | WO | claimed |
| EP-0186028-B1 | OPTICALLY ACTIVE NITRODIHYDROPYRIDINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINES | BAYER AG (DE) | 1990-08-01 | — | — | EP | claimed |
| EP-0211584-A1 | Antihypertensive agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-02-25 | — | — | EP | claimed |
| EP-0093010-B1 | ALPHA-HYDROXYETHYLPHOSPHINATES, AND THEIR PRODUCTION AND USE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-06-11 | — | — | EP | claimed |
| EP-0026317-B1 | OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | BAYER AG (DE) | 1985-10-16 | — | — | EP | claimed |
| EP-0157415-A2 | Pyrazolo[4,3-d] pyrimidine derivative process for its production antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1985-10-09 | — | — | EP | claimed |
| EP-0101023-A1 | Process for preparing 2-carbamoyloxyalkyl-1,4-dihydropyridine derivatives and intermediates useful for the process | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1984-02-22 | — | — | EP | claimed |
| US-3971804-A | ACARICIDES, FUNGICIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10071984-B2 | Histone demethylase inhibitors | KDM1B, KDM1A, KDM3B | KMT2A 40/4885EPHX1 1289/4885THRB 3279/4885 |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | KMT2A 4001/4885EPHX1 384/4885THRB 4227/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | KMT2A 4001/4885EPHX1 384/4885THRB 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.